News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.

Isogenica’s
Latest News
PRESS RELEASES

Isogenica-Phenotypeca Further Collaboration through Medilink Award
Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Isogenica are furthering their collaboration with Phenotypeca, whose platform will deploy yeast-display for multivalent...
Isogenica-Phenotypeca SMART Grant Collaboration
Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions...
Isogenica-PipeBio Collaboration Press Release
Isogenica announce deployment of the PipeBio Bioinformatic Cloud Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...
ANNOUNCEMENTS
Catch up on Isogenica’s latest activities.
CHI Sixth Annual Immuno-Oncology Summit Europe
Join Isogenica in London at the Annunal Immuno-Oncology SummitThe Isogenica team will be attending in person at CHI's annual Immuno-Oncology conference, taking place on 23rd-25th May....
Machine Learning – Antibody Discovery Scientist KTP Award
University of Nottingham is inviting applications for a Machine Learning - Antibody Discovery Scientist to join an exciting collaboration with Isogenica. As an enthusiastic graduate, this is a...
POSTER: PEGS 2021
Isogenica is excited to announce its corporate sponsorship at PEGS November 2-4th 2021Isogenica is delighted to announce its successful attendance at PEGS Europe 2021 as Corporate Sponsors, were...
WEBINARS
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
Nature Webinar
Register for Isogenica's upcoming webinar Join Isogenica for the upcoming webinar with Nature on 'VHH as building blocks for immune and tumour cell-targeting', presented by Isogenica's CSO Bill...

RESOURCES
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
Neurodegenerative Diseases
The advantages of VHH in Neurodegenerative Diseases.
VHH antibodies as biotherapeutics
Camelid heavy-chain only antibodies were discovered in the early 1990’s. Often referred to as VHH antibodies, they are a well characterized alternative to therapeutic IgG’s. Camelid heavy-chain only...
Upcoming
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.
